MedPath

SAHMRI INVESTMENTS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

25

Active:2
Completed:6

Trial Phases

5 Phases

Phase 1:1
Phase 2:3
Phase 3:2
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials

Not Applicable
12 (50.0%)
Phase 4
6 (25.0%)
Phase 2
3 (12.5%)
Phase 3
2 (8.3%)
Phase 1
1 (4.2%)

Antibiotics and Vaccine Immune Responses Study

Phase 4
Recruiting
Conditions
Vaccine Response Impaired
Interventions
Biological: BCG vaccine
Biological: Yellow Fever vaccine
First Posted Date
2023-11-28
Last Posted Date
2024-04-04
Lead Sponsor
South Australian Health and Medical Research Institute
Target Recruit Count
348
Registration Number
NCT06148025
Locations
🇦🇺

South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Not Applicable
Completed
Conditions
Iron-deficiency
Microbial Colonization
Anemia
First Posted Date
2021-09-02
Last Posted Date
2023-04-12
Lead Sponsor
South Australian Health and Medical Research Institute
Target Recruit Count
82
Registration Number
NCT05033483
Locations
🇦🇺

SAHMRI, Adelaide, South Australia, Australia

Prenatal Iodine Supplementation and Early Childhood Neurodevelopment

Phase 4
Active, not recruiting
Conditions
Pregnancy Related
Nutrition Disorder, Fetal
Neurodevelopmental Disorders
First Posted Date
2020-10-14
Last Posted Date
2024-04-03
Lead Sponsor
South Australian Health and Medical Research Institute
Target Recruit Count
794
Registration Number
NCT04586348
Locations
🇦🇺

South Australian Health and Medical Research Institute, North Adelaide, South Australia, Australia

News

Magnesium Sulfate Prevents Cerebral Palsy in Premature Babies: Cochrane Review

A Cochrane review confirms that magnesium sulfate infusions given to women at risk of premature birth can prevent cerebral palsy in their babies.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.